A carregar...
Intractable and highly active relapsing multiple sclerosis – role of alemtuzumab
Alemtuzumab is a humanized recombinant monoclonal antibody that was recently approved by the US Food and Drug Administration and the European Medicines Agency for the management of relapsing forms of multiple sclerosis (MS). It has been utilized for the management of chronic lymphocytic leukemia, bo...
Na minha lista:
| Publicado no: | Neuropsychiatr Dis Treat |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4581781/ https://ncbi.nlm.nih.gov/pubmed/26425095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S90473 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|